Cargando…
Progastrin production transitions from Bmi1(+)/Prox1(+) to Lgr5(high) cells during early intestinal tumorigenesis
Progastrin is an unprocessed soluble peptide precursor with a well-described tumor-promoting role in colorectal cancer. It is expressed at small levels in the healthy intestinal mucosa, and its expression is enhanced at early stages of intestinal tumor development, with high levels of this peptide i...
Autores principales: | Giraud, J., Foroutan, M., Boubaker-Vitre, J., Grillet, F., Homayed, Z., Jadhav, U., Crespy, P., Breuker, C., Bourgaux, J-F., Hazerbroucq, J., Pignodel, C., Brulin, B., Shivdasani, R.A., Jay, P., Hollande, F., Pannequin, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772574/ https://www.ncbi.nlm.nih.gov/pubmed/33360299 http://dx.doi.org/10.1016/j.tranon.2020.101001 |
Ejemplares similares
-
Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium
por: Gerbe, François, et al.
Publicado: (2011) -
CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM
por: Belthier, Guillaume, et al.
Publicado: (2021) -
Targeting progastrin enhances radiosensitization of colorectal cancer cells
por: Kowalski-Chauvel, Aline, et al.
Publicado: (2017) -
Acute effects of N‐terminal progastrin fragments on gastric acid secretion in man
por: Goetze, Jens P., et al.
Publicado: (2017) -
Association between Serum Progastrin Biomarker Level and Gastric Cancer
por: Amjadi, Omolbanin, et al.
Publicado: (2022)